The worldwide prevalence of metastatic colorectal cancer constitutes a significant healthcare crisis, demanding comprehensive therapeutic innovations that address complex disease biology and diverse patient populations. This malignancy's progression from localized to systemic disease creates substantial clinical management challenges while generating significant opportunities within the...